TCMD, US87357P1003

BTIG cuts target for Tactile Systems Technology stock to USD 35.00

Published on 10/15/2026 at 13:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BTIG cut its target from USD 39 to USD 35 on October 12, 2026. Tactile Systems Technology stock costs EUR 20.03 on October 15, 2026.

Analyst target and earnings

  • BTIG cut its Tactile Systems Technology target from USD 39.00 to USD 35.00 on October 12, 2026.
  • Second-quarter 2026 revenue reached USD 85.70 million and diluted earnings per share were USD 0.34.
  • Tactile Systems Technology stock traded at EUR 20.03 at 1:40 p.m. CEST at Lang & Schwarz on October 15, 2026.
TCMD, US87357P1003, Illustration mit AI erstellt.
TCMD, US87357P1003, Illustration mit AI erstellt.

Tactile Systems Technology (ISIN US87357P1003) was trading at EUR 20.03 at Lang & Schwarz on October 15, 2026 at 1:40 p.m. CEST. On October 12, 2026, Markets Insider reported that BTIG cut its target from USD 39.00 to USD 35.00 while keeping a Buy rating. The lower target puts the analyst call against the companys recent earnings performance rather than replacing it.

Quarterly figures set the backdrop

For the second quarter of 2026, Tactile Medical generated USD 85.70 million in revenue, while diluted earnings per share reached USD 0.34 and net income was USD 7.79 million. Revenue rose from USD 75.27 million in the first quarter of 2026, and the company moved from a diluted loss of USD 0.08 per share to diluted earnings of USD 0.34 per share.

MarketBeat said the second-quarter result exceeded the USD 0.14 consensus estimate, while revenue was above the USD 85.52 million consensus. That comparison gives the target cut a measurable counterpoint: earnings outperformed expectations even as BTIG reduced its valuation benchmark.

Three dates show the change

On August 10, 2026, Tactile Medical reported second-quarter diluted earnings per share of USD 0.34. On September 28, 2026, Weiss Ratings cut its rating from hold c+ to hold c. On October 12, 2026, BTIG reduced its target from USD 39.00 to USD 35.00 while retaining a Buy rating.

What comes next for earnings?

MarketBeat lists November 2, 2026 as the estimated date for Tactile Medical to report third-quarter 2026 results, with the conference call scheduled for 5:00 p.m. ET. Its consensus calls for USD 91.99 million in revenue and USD 0.30 in earnings per share, giving investors two concrete benchmarks for the next report.

Trading stays tied to the target

The Lang & Schwarz quote places the stock at EUR 20.03 on October 15, 2026 at 1:40 p.m. CEST. The market story therefore combines a fresh analyst target cut with a recent quarter that exceeded its earnings and revenue comparisons.

The further course of trading is shown by the continuously updated real-time quote of Tactile Systems Technology stock.

TCMD trading facts

  • Company: Tactile Systems Technology, Inc.
  • ISIN: US87357P1003
  • Ticker: TCMD
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 15, 2026, 1:40 p.m. CEST): EUR 20.03
  • Market capitalization: USD 507.6 million (as of October 14, 2026)
  • Sector / Industry: Healthcare / Medical Devices

Market context: Market report S&P 500.

More news and analyses on Tactile Systems Technology stock

Disclaimer...

en | US87357P1003 | TCMD | boerse | 70329783 | bgmi